254 related articles for article (PubMed ID: 19644876)
1. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
[TBL] [Abstract][Full Text] [Related]
2. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors.
Suarez-Gestal M; Calaza M; Dieguez-Gonzalez R; Perez-Pampin E; Pablos JL; Navarro F; Narvaez J; Marenco JL; Herrero-Beaumont G; Fernandez-Gutierrez B; Lamas JR; de la Serna AR; Ortiz AM; Carreño L; Cañete JD; Caliz R; Blanco FJ; Balsa A; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2009 Sep; 60(9):2558-64. PubMed ID: 19714582
[TBL] [Abstract][Full Text] [Related]
4. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
Svenungsson E; Gustafsson J; Leonard D; Sandling J; Gunnarsson I; Nordmark G; Jönsen A; Bengtsson AA; Sturfelt G; Rantapää-Dahlqvist S; Elvin K; Sundin U; Garnier S; Simard JF; Sigurdsson S; Padyukov L; Syvänen AC; Rönnblom L
Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
[TBL] [Abstract][Full Text] [Related]
5. Population differences in SLE susceptibility genes: STAT4 and BLK, but not PXK, are associated with systemic lupus erythematosus in Hong Kong Chinese.
Yang W; Ng P; Zhao M; Hirankarn N; Lau CS; Mok CC; Chan TM; Wong RW; Lee KW; Mok MY; Wong SN; Avihingsanon Y; Lee TL; Ho MH; Lee PP; Wong WH; Lau YL
Genes Immun; 2009 Apr; 10(3):219-26. PubMed ID: 19225526
[TBL] [Abstract][Full Text] [Related]
6. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
7. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
Dieudé P; Wipff J; Guedj M; Ruiz B; Melchers I; Hachulla E; Riemekasten G; Diot E; Hunzelmann N; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Nov; 60(11):3447-54. PubMed ID: 19877059
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
[TBL] [Abstract][Full Text] [Related]
9. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4.
Wang C; Sandling JK; Hagberg N; Berggren O; Sigurdsson S; Karlberg O; Rönnblom L; Eloranta ML; Syvänen AC
Ann Rheum Dis; 2013 Jan; 72(1):96-103. PubMed ID: 22730365
[TBL] [Abstract][Full Text] [Related]
11. Gene-gene interaction of ATG5, ATG7, BLK and BANK1 in systemic lupus erythematosus.
Dang J; Li J; Xin Q; Shan S; Bian X; Yuan Q; Liu N; Ma X; Li Y; Liu Q
Int J Rheum Dis; 2016 Dec; 19(12):1284-1293. PubMed ID: 26420661
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
13. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
[TBL] [Abstract][Full Text] [Related]
14. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
16. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk.
Abelson AK; Delgado-Vega AM; Kozyrev SV; Sánchez E; Velázquez-Cruz R; Eriksson N; Wojcik J; Linga Reddy MV; Lima G; D'Alfonso S; Migliaresi S; Baca V; Orozco L; Witte T; Ortego-Centeno N; ; Abderrahim H; Pons-Estel BA; Gutiérrez C; Suárez A; González-Escribano MF; Martin J; Alarcón-Riquelme ME
Ann Rheum Dis; 2009 Nov; 68(11):1746-53. PubMed ID: 19019891
[TBL] [Abstract][Full Text] [Related]
17. Variation in STAT4 is associated with systemic lupus erythematosus in a Finnish family cohort.
Hellquist A; Sandling JK; Zucchelli M; Koskenmies S; Julkunen H; D'Amato M; Garnier S; Syvänen AC; Kere J
Ann Rheum Dis; 2010 May; 69(5):883-6. PubMed ID: 19717398
[TBL] [Abstract][Full Text] [Related]
18. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
Kobayashi S; Ikari K; Kaneko H; Kochi Y; Yamamoto K; Shimane K; Nakamura Y; Toyama Y; Mochizuki T; Tsukahara S; Kawaguchi Y; Terai C; Hara M; Tomatsu T; Yamanaka H; Horiuchi T; Tao K; Yasutomo K; Hamada D; Yasui N; Inoue H; Itakura M; Okamoto H; Kamatani N; Momohara S
Arthritis Rheum; 2008 Jul; 58(7):1940-6. PubMed ID: 18576330
[TBL] [Abstract][Full Text] [Related]
19. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
[TBL] [Abstract][Full Text] [Related]
20. Association of the FAM167A-BLK region with systemic sclerosis.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
